EUVIMEDScopri EUVIMED
Crossref

Long-term confinement triggers RIPK3-independent necroptosis in amoeboid cancer cells to shape tumor evolution

Wei Zhang, Ya-Jun Wang, Chunman Zuo, Junyi He, Xuying Ma, Haoran Wu, Bao-Qiong Lan, Dehui Kong, Luonan Chen, Gang Wei, Na Yang, Yuandi Fu and 3 more

Developmental Cell · 2026

DOI: 10.1016/j.devcel.2026.09.003 ↗

At a glance

Journal article in Developmental Cell, 2026. Written by Wei Zhang and 14 co-authors. Institution: Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese A…. Major MEDLINE topics: Necroptosis, Receptor-Interacting Protein Serine-Threonine Kinases, Neoplasms. Cited 1 times so far (Crossref); 72 references. Funded by: Innovative Research Team of High-level Local University in Shanghai, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The mesenchymal-amoeboid transition (MAT) enhances cancer cell migration and therapy resistance during dissemination through mechanically confined spaces. Using an in vitro MAT induction system combining physical confinement with a non-adhesive environment to mimic interstitial migration, we introduce "long-term MAT" (L-MAT) to describe cells sustaining MAT under prolonged pressure and show that L-MAT triggers receptor-interacting protein kinase 3 (RIPK3)-independent necroptosis. Mechanistically, the PIEZO1-STAT1 axis upregulates mixed lineage kinase domain-like pseudokinase (MLKL), whose membrane accumulation drives necroptosis in cells otherwise resistant to death-receptor signaling. Before membrane rupture, L-MAT cells show progressive migration restriction; MLKL-knockout cells bypass this checkpoint and persist as surviving clones. Spatial transcriptomics of patient tumors shows MLKL expression correlates with PIEZO1 activation and immunogenicity in less aggressive regions, while advanced malignant and metastatic clones show reduced MLKL. These findings establish MLKL as a conditional tumor checkpoint and identify the PIEZO1-STAT1-MLKL axis as a predictive biomarker and therapeutic target.

Subjects

MeSH terms (MEDLINE)

NecroptosisReceptor-Interacting Protein Serine-Threonine KinasesNeoplasmsHumansProtein KinasesSTAT1 Transcription FactorIon ChannelsCell MovementCell Line, TumorAnimalsSignal TransductionEpithelial-Mesenchymal Transition

Author keywords

MLKLPIEZO1RIPK3-independent necroptosisamoeboid migrationmechanical confinementmesenchymal-amoeboid transitionnecroptosisspatial transcriptomicstumor checkpointtumor evolution

Substances

Receptor-Interacting Protein Serine-Threonine KinasesProtein KinasesMLKL protein, humanRIPK3 protein, humanSTAT1 Transcription FactorIon ChannelsPIEZO1 protein, humanSTAT1 protein, human

Authors and institutions

  • Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
  • Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Institutes of Biomedical Sciences, Fudan University, Shanghai 20003…
  • State Key Laboratory of Biocontrol, Innovation Center for Evolutionary Synthetic Biology, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.
  • Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China; Key Laboratory of Molecular Virology a…
  • Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China; Key Laboratory of Systems…
  • Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China.

Funding

  • Innovative Research Team of High-level Local University in Shanghai
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program

Cite

APA

Zhang, W., Wang, Y. J., Zuo, C., He, J., Ma, X., Wu, H., Lan, B. Q., Kong, D., Chen, L., Wei, G., Yang, N., Fu, Y., Liu, D., Liu, Y. J., & Sun, L. (2026). Long-term confinement triggers RIPK3-independent necroptosis in amoeboid cancer cells to shape tumor evolution. Developmental Cell. https://doi.org/10.1016/j.devcel.2026.09.003

Vancouver

Zhang W, Wang YJ, Zuo C, He J, Ma X, Wu H, et al. Long-term confinement triggers RIPK3-independent necroptosis in amoeboid cancer cells to shape tumor evolution. Developmental Cell. 2026. doi:10.1016/j.devcel.2026.09.003

BibTeX
@article{Zhang2026,
  author = {Zhang, Wei and Wang, Ya-Jun and Zuo, Chunman and He, Junyi and Ma, Xuying and Wu, Haoran and Lan, Bao-Qiong and Kong, Dehui and Chen, Luonan and Wei, Gang and Yang, Na and Fu, Yuandi and Liu, Dan and Liu, Yan-Jun and Sun, Liming},
  title = {Long-term confinement triggers RIPK3-independent necroptosis in amoeboid cancer cells to shape tumor evolution},
  journal = {Developmental Cell},
  year = {2026},
  doi = {10.1016/j.devcel.2026.09.003}
}
Start for free →